Breast Cancer Trial Results
Study Confirms Risk of Bone Loss for Patients Taking Exemestane
(Posted: 02/14/2007) - Women who switched to the drug exemestane after taking tamoxifen to prevent a breast cancer relapse lost more bone density and had a higher risk of bone fractures than women who continued taking tamoxifen, according to a report published online Jan. 26, 2007, by Lancet Oncology.
(Posted: 02/14/2007) - Women who switched to the drug exemestane after taking tamoxifen to prevent a breast cancer relapse lost more bone density and had a higher risk of bone fractures than women who continued taking tamoxifen, according to a report published online Jan. 26, 2007, by Lancet Oncology.
